(Q46049758)

19 December 2017

title

Effect of dietary purines on the pharmacokinetics of orally administered ribavirin (English)

1 reference

19 December 2017

1 reference

1 reference

Linghui Li

1

1 reference

19 December 2017

Seok Hwee Koo

2

1 reference

19 December 2017

Lie Michael George Limenta

3

1 reference

19 December 2017

Li Han

4

1 reference

19 December 2017

Khadijah Binte Hashim

5

1 reference

19 December 2017

Hung Hiang Quek

6

1 reference

19 December 2017

Edmund Jon Deoon Lee

7

1 reference

19 December 2017

publication date

15 April 2009

1 reference

19 December 2017

The Journal of Clinical Pharmacology

published in

1 reference

19 December 2017

volume

49

1 reference

19 December 2017

issue

6

1 reference

19 December 2017

page(s)

661-667

1 reference

19 December 2017

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0091270009335002

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009335002

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009335002

High-dose ribavirin in combination with standard dose peginterferon for treatment of patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009335002

Evidence that plasma concentration rather than dose per kilogram body weight predicts ribavirin-induced anaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009335002

The concentrative nucleoside transporter family, SLC28

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009335002

Functional expression and characterization of a sodium-dependent nucleoside transporter hCNT2 cloned from human duodenum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009335002

Intestinal absorption of ribavirin is preferentially mediated by the Na+-nucleoside purine (N1) transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009335002

Ribavirin disposition in high-risk patients for acquired immunodeficiency syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009335002

Absence of clinically relevant pharmacokinetic interaction between ribavirin and tenofovir in healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009335002

Molecular cloning, functional expression and chromosomal localization of a cDNA encoding a human Na+/nucleoside cotransporter (hCNT2) selective for purine nucleosides and uridine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009335002

Genetic analysis and functional characterization of polymorphisms in the human concentrative nucleoside transporter, CNT2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009335002

Differences in treatment outcome for hepatitis C among ethnic groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009335002

Southeast Asian patients with chronic hepatitis C: the impact of novel genotypes and race on treatment outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009335002

21 January 2018

Identifiers

DOI

10.1177/0091270009335002

1 reference

19 December 2017

1 reference

19 December 2017